- Home
- LFWD vs EVAX Comparison
LFWD vs EVAX Comparison
Compare LFWD & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFWD
- EVAX
- Stock Information
- Founded
- LFWD 2001
- EVAX 2008
- Country
- LFWD Israel
- EVAX Denmark
- Employees
- LFWD N/A
- EVAX N/A
- Industry
- LFWD
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LFWD
- EVAX Health Care
- Exchange
- LFWD NYSE
- EVAX Nasdaq
- Market Cap
- LFWD 14.9M
- EVAX 16.3M
- IPO Year
- LFWD 2014
- EVAX 2021
- Fundamental
- Price
- LFWD $1.48
- EVAX $1.49
- Analyst Decision
- LFWD Strong Buy
- EVAX Strong Buy
- Analyst Count
- LFWD 3
- EVAX 2
- Target Price
- LFWD $9.00
- EVAX $10.00
- AVG Volume (30 Days)
- LFWD 182.3K
- EVAX 76.2K
- Earning Date
- LFWD 05-14-2025
- EVAX 05-27-2025
- Dividend Yield
- LFWD N/A
- EVAX N/A
- EPS Growth
- LFWD N/A
- EVAX N/A
- EPS
- LFWD N/A
- EVAX N/A
- Revenue
- LFWD $25,663,000.00
- EVAX $3,344,000.00
- Revenue This Year
- LFWD $16.16
- EVAX $102.45
- Revenue Next Year
- LFWD $51.10
- EVAX $100.30
- P/E Ratio
- LFWD N/A
- EVAX N/A
- Revenue Growth
- LFWD 85.24
- EVAX 4480.82
- 52 Week Low
- LFWD $1.22
- EVAX $1.20
- 52 Week High
- LFWD $5.28
- EVAX $21.80
- Technical
- Relative Strength Index (RSI)
- LFWD 46.83
- EVAX 43.19
- Support Level
- LFWD $1.37
- EVAX $1.20
- Resistance Level
- LFWD $1.50
- EVAX $1.46
- Average True Range (ATR)
- LFWD 0.11
- EVAX 0.13
- MACD
- LFWD 0.00
- EVAX 0.03
- Stochastic Oscillator
- LFWD 57.78
- EVAX 59.18
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.